[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69715181D1 - Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator - Google Patents

Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator

Info

Publication number
DE69715181D1
DE69715181D1 DE69715181T DE69715181T DE69715181D1 DE 69715181 D1 DE69715181 D1 DE 69715181D1 DE 69715181 T DE69715181 T DE 69715181T DE 69715181 T DE69715181 T DE 69715181T DE 69715181 D1 DE69715181 D1 DE 69715181D1
Authority
DE
Germany
Prior art keywords
peptide
calcium channel
acetylcholinesterase
activity
soluble form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69715181T
Other languages
English (en)
Other versions
DE69715181T2 (de
Inventor
Adele Greenfield
John Vaux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synaptica Ltd
Original Assignee
Synaptica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synaptica Ltd filed Critical Synaptica Ltd
Application granted granted Critical
Publication of DE69715181D1 publication Critical patent/DE69715181D1/de
Publication of DE69715181T2 publication Critical patent/DE69715181T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69715181T 1996-03-22 1997-03-21 Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator Expired - Lifetime DE69715181T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9606040.5A GB9606040D0 (en) 1996-03-22 1996-03-22 Active peptide
PCT/GB1997/000796 WO1997035962A1 (en) 1996-03-22 1997-03-21 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator

Publications (2)

Publication Number Publication Date
DE69715181D1 true DE69715181D1 (de) 2002-10-10
DE69715181T2 DE69715181T2 (de) 2003-04-30

Family

ID=10790837

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69715181T Expired - Lifetime DE69715181T2 (de) 1996-03-22 1997-03-21 Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator

Country Status (10)

Country Link
US (1) US7018839B2 (de)
EP (2) EP1270594A1 (de)
JP (1) JP2000509967A (de)
AT (1) ATE223481T1 (de)
DE (1) DE69715181T2 (de)
DK (1) DK0896615T3 (de)
ES (1) ES2180948T3 (de)
GB (1) GB9606040D0 (de)
PT (1) PT896615E (de)
WO (1) WO1997035962A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL130225A0 (en) * 1999-05-31 2000-06-01 Yissum Res Dev Co Novel uses of antibodies against ache and peptides thereof
GB9930825D0 (en) * 1999-12-30 2000-02-16 Synaptica Limited Animal models for neurodegenerative disease
US20040038875A1 (en) * 2000-03-29 2004-02-26 Greenfield Susan Adele Alpha 7nicotinic receptor screening assays
GB0028578D0 (en) * 2000-11-23 2001-01-10 Synaptica Ltd Screening assays
JP2006525405A (ja) 2003-05-05 2006-11-09 ベン‐グリオン ユニバーシティ オブ ザ ネゲヴ リサーチ アンド デベロップメント オーソリティ 注入可能な架橋されたポリマー調製物およびその使用
WO2005066337A2 (en) * 2004-01-09 2005-07-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compounds, pharmaceutical compositions and therapeutic methods of preventing and treating diseases and disorders associated with amyloid fibril formation
CN1772766A (zh) * 2004-11-12 2006-05-17 中国科学院上海生命科学研究院 抗细胞凋亡相关乙酰胆碱酯酶单克隆抗体及其用途
GB0708646D0 (en) * 2007-05-04 2007-06-13 Enkephala Ltd Biologically active C-terminal fragment of acetylcholinesterase
GB2539161A (en) * 2014-11-26 2016-12-14 Neuro-Bio Ltd Neurodegenerative disorders
WO2016097753A1 (en) * 2014-12-19 2016-06-23 Neuro-Bio Ltd Cyclic acetylcholinesterase c-terminal peptide in the treatment or prevention of cancer or metastasis
GB2538947A (en) 2014-12-19 2016-12-07 Neuro-Bio Ltd Cancer
GB201505239D0 (en) * 2015-03-27 2015-05-13 Neuro Bio Ltd Antibody
GB2546773B (en) * 2016-01-28 2020-06-17 Neuro Bio Ltd Cancer
CN110028550B (zh) * 2016-07-07 2022-08-05 华东理工大学 降血压肽和降血压蛋白质及其应用
CN110305224B (zh) * 2019-06-28 2021-07-13 天津科技大学 一种具有阻抗蛋白聚集功能的Aβ42修饰蛋白及其表达与纯化方法
GB2587211A (en) 2019-09-18 2021-03-24 Neuro Bio Ltd Animal model
GB202113941D0 (en) * 2021-09-29 2021-11-10 Neuro Bio Ltd Skin biomarker

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8709400D0 (en) * 1987-04-21 1987-05-28 Smith A D Acetylcholinesterase
GB8927389D0 (en) * 1989-12-04 1990-01-31 Jehanli Ahmed M T Monoclonal antibodies
US5932780A (en) * 1994-02-28 1999-08-03 Yissum Research Development Company Of Hebrew University Of Jerusalem Transgenic non-human animal assay system for anti-cholinesterase substances
GB0028578D0 (en) * 2000-11-23 2001-01-10 Synaptica Ltd Screening assays

Also Published As

Publication number Publication date
WO1997035962A1 (en) 1997-10-02
JP2000509967A (ja) 2000-08-08
EP1270594A1 (de) 2003-01-02
US20020054870A1 (en) 2002-05-09
US7018839B2 (en) 2006-03-28
PT896615E (pt) 2003-01-31
EP0896615B1 (de) 2002-09-04
EP0896615A1 (de) 1999-02-17
DE69715181T2 (de) 2003-04-30
ATE223481T1 (de) 2002-09-15
DK0896615T3 (da) 2003-01-06
ES2180948T3 (es) 2003-02-16
GB9606040D0 (en) 1996-05-22

Similar Documents

Publication Publication Date Title
ATE223481T1 (de) Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator
IL113617A0 (en) Soluble polypeptide fraction
DE60141546D1 (de) Polypeptide enthaltend extrazellulären Domäne von IL-20RA und/oderr IL-20RB
DK0792287T3 (da) Peptidanaloger af humant basisk myelinprotein
ATE368053T1 (de) Antimikrobielle peptide
GB9828628D0 (en) Novel ligand
DE68927379D1 (de) Plättchen blockierende peptide
EP1006126A3 (de) Peptide mit osteogener Aktivität
ES2058479T3 (es) Compuestos peptidicos.
AU634280B2 (en) Anticoagulant peptides
IL92551A0 (en) Anticoagulant peptides
DE69738600D1 (de) Neuroaktive peptide
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition